KLHL11 paraneoplastic encephalitis: management
Evidence-based neurology checklist on klhl11 paraneoplastic encephalitis: management: Magnetic resonance imaging (MRI) brain T2 hyperintensities on T2 FLAIR Low-signal intensity on susceptibility-weighted imaging (SWI) Brainstem and cerebellar atrophy Hot-cross-bun sign Other investigations…
Magnetic resonance imaging (MRI) brain
- T2 hyperintensities on T2 FLAIR
- Low-signal intensity on susceptibility-weighted imaging (SWI)
- Brainstem and cerebellar atrophy
- Hot-cross-bun sign
Other investigations
Treatment
References
- Ishikawa H, Mandel-Brehm C, Shindo A, et al. Long-term MRI changes in a patient with Kelch-like protein 11-associated paraneoplastic neurological syndrome. Eur J Neurol 2021; 28:4261-4266.
- Jin M, Brand T, Erdag Turgeon E, et al. Clinical manifestations, tumor associations, and long-term outcomes of anti-KLHL11 encephalitis. Neurol Neuroimmunol Neuroinflamm 2026; 13:e200597.
- Song Y, Hu Q, Zhang Q. Anti-Kelch-like protein 11 antibody encephalitis: a case report and literature review. Front Neurol 2023; 14:1273051.
- Dubey D, Wilson MR, Clarkson B, et al. Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic kelch-like protein-11 encephalitis. JAMA Neurol 2020; 77:1420-1429.
